Market Closed -
Nyse
04:00:02 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
554.4
USD
|
+1.13%
|
|
-0.18%
|
-5.20%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,032
|
8,456
|
8,109
|
7,590
|
8,776
|
8,362
|
-
|
-
|
Enterprise Value (EV)
1 |
7,116
|
8,456
|
8,109
|
7,590
|
8,776
|
8,362
|
8,362
|
8,362
|
P/E ratio
|
33
x
|
27.3
x
|
31.4
x
|
30.5
x
|
32.6
x
|
27.1
x
|
23.7
x
|
-
|
Yield
|
0.28%
|
0.25%
|
0.26%
|
0.29%
|
0.27%
|
0.3%
|
0.31%
|
-
|
Capitalization / Revenue
|
3.63
x
|
4.07
x
|
3.79
x
|
3.56
x
|
3.88
x
|
3.44
x
|
3.22
x
|
3.03
x
|
EV / Revenue
|
3.63
x
|
4.07
x
|
3.79
x
|
3.56
x
|
3.88
x
|
3.44
x
|
3.22
x
|
3.03
x
|
EV / EBITDA
|
20
x
|
19
x
|
17.6
x
|
16.8
x
|
19.4
x
|
16.4
x
|
15.3
x
|
14.4
x
|
EV / FCF
|
28,329,822
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
9.65
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
16,009
|
15,876
|
15,328
|
14,870
|
15,008
|
15,084
|
-
|
-
|
Reference price
2 |
439.3
|
532.6
|
529.0
|
510.4
|
584.8
|
554.4
|
554.4
|
554.4
|
Announcement Date
|
2/18/20
|
2/23/21
|
2/24/22
|
2/23/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,939
|
2,080
|
2,139
|
2,135
|
2,264
|
2,430
|
2,594
|
2,763
|
EBITDA
1 |
350.9
|
444.8
|
461.4
|
452.3
|
451.9
|
509.2
|
548.1
|
579.9
|
EBIT
1 |
301.4
|
389.7
|
404.9
|
412.1
|
393.8
|
417.8
|
469.7
|
523.7
|
Operating Margin
|
15.55%
|
18.74%
|
18.93%
|
19.3%
|
17.39%
|
17.2%
|
18.11%
|
18.95%
|
Earnings before Tax (EBT)
1 |
261.6
|
396
|
350.3
|
329.7
|
350.4
|
403.7
|
456.4
|
-
|
Net income
1 |
219.9
|
319.5
|
268.6
|
249.6
|
272.5
|
313.3
|
356.1
|
-
|
Net margin
|
11.34%
|
15.36%
|
12.55%
|
11.69%
|
12.03%
|
12.89%
|
13.73%
|
-
|
EPS
2 |
13.31
|
19.48
|
16.85
|
16.72
|
17.93
|
20.46
|
23.36
|
-
|
Free Cash Flow
|
248.2
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
12.8%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
70.73%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
112.87%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
1.240
|
1.320
|
1.400
|
1.480
|
1.560
|
1.640
|
1.722
|
-
|
Announcement Date
|
2/18/20
|
2/23/21
|
2/24/22
|
2/23/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
541
|
530.5
|
531.3
|
526.5
|
546.7
|
560.2
|
553.8
|
564.5
|
585.9
|
589.2
|
599.2
|
609.4
|
631.8
|
637.3
|
647
|
EBITDA
1 |
122.6
|
110.2
|
110.9
|
108.7
|
122.5
|
111
|
109.1
|
115.8
|
139.6
|
114.6
|
124.2
|
128.6
|
141.8
|
126.8
|
135
|
EBIT
1 |
112
|
101.8
|
103.1
|
99.58
|
107.6
|
98.84
|
94.84
|
98.55
|
125.3
|
92.83
|
101.5
|
107.8
|
121.8
|
107.1
|
121.2
|
Operating Margin
|
20.71%
|
19.2%
|
19.41%
|
18.92%
|
19.68%
|
17.64%
|
17.13%
|
17.46%
|
21.39%
|
15.75%
|
16.93%
|
17.69%
|
19.27%
|
16.81%
|
18.74%
|
Earnings before Tax (EBT)
1 |
96.13
|
84.7
|
86.11
|
76.47
|
82.4
|
71.16
|
70.34
|
93.26
|
115.6
|
84.48
|
104.2
|
103.1
|
113.6
|
-
|
-
|
Net income
1 |
74.62
|
64.17
|
66.46
|
56.87
|
62.13
|
54.12
|
53.38
|
74.96
|
90.05
|
65.02
|
77.51
|
80.71
|
90.03
|
83.25
|
-
|
Net margin
|
13.79%
|
12.09%
|
12.51%
|
10.8%
|
11.36%
|
9.66%
|
9.64%
|
13.28%
|
15.37%
|
11.03%
|
12.94%
|
13.24%
|
14.25%
|
13.06%
|
-
|
EPS
2 |
4.810
|
4.220
|
4.400
|
3.780
|
4.130
|
3.580
|
3.510
|
4.930
|
5.900
|
4.240
|
5.060
|
5.275
|
5.890
|
5.450
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/24/22
|
4/26/22
|
7/27/22
|
10/31/22
|
2/23/23
|
4/26/23
|
7/26/23
|
10/25/23
|
2/27/24
|
4/24/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
83.8
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.2389
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
248
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
33.4%
|
39.3%
|
35.2%
|
41.9%
|
32.4%
|
30.6%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
19.6%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
1,122
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
45.50
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
18.20
|
29.80
|
19.40
|
20.50
|
21.70
|
25.10
|
28.30
|
-
|
Capex
|
53
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
2.74%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/18/20
|
2/23/21
|
2/24/22
|
2/23/23
|
2/27/24
|
-
|
-
|
-
|
Last Close Price
554.4
USD Average target price
685
USD Spread / Average Target +23.56% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.20% | 8.36B | | +25.52% | 88.99B | | -24.52% | 74.82B | | -1.34% | 25.03B | | +4.31% | 17.88B | | -14.25% | 16.43B | | +2.97% | 15.77B | | +79.20% | 13.21B | | +70.11% | 13.08B | | +40.44% | 12.9B |
Other Healthcare Facilities & Services
|